loading page

Quantum Chemical Investigation on Hydrolysis of Osmium(III) Anticancer Drug, (ImH)[trans-OsCl4(DMSO)(Im)] (Im=imidazole, Os-NAMI-A) and its Interaction with DNA
  • Paritosh Mondal,
  • Amit Pradhan,
  • Abhijit Shyam
Paritosh Mondal
Assam University
Author Profile
Amit Pradhan
Assam University
Author Profile
Abhijit Shyam
Assam University
Author Profile


Osmium analogue to ruthenium anticancer drug NAMI-A; (ImH)[trans-OsCl4(DMSO)(Im)] (Im=imidazole, DMSO=dimethyl sulfoxide) (Os-NAMI-A) shows a three-fold higher activity in colon carcinoma. Hydrolysis mechanism of Os-NAMI-A has been investigated using density functional theory (DFT) in combination with CPCM solvation model. Calculated activation free energy values for the first chloro ligand hydrolysis in the gaseous and aqueous medium are found to be ΔGg=31.79 and ΔGaq=28.72 kcal/mol, respectively. While, activation free energy for the second cis chloro ligand hydrolysis calculated in the gas and solvent phases are observed to be significantly lower (ΔGg=29.12 and ΔGaq=22.61 kcal/mol), suggesting enhanced feasibility of second hydrolysis. However, hydrolysis of DMSO ligand in the formation of cis-[OsCl2(H2O)3(Im)]+ (P-3cis) is found to be thermodynamically preferred in aqueous medium (19.49 kcal/mol) with rate constant value of 3.20×10-2 s-1. In addition, molecular docking simulation reveals that cis-diaquated Os-NAMI-A (P-2cis) interacts with DNA (PDB ID: 1pgc) more effectively having binding energy -5.63 kcal/mol. Therefore, results of this investigation may lead us to understand the solution behaviour of osmium azole complexes as well as their mode of interaction with biomolecules which in return helps in potential anticancer drug designing.

Peer review status:UNDER REVIEW

20 May 2020Submitted to International Journal of Quantum Chemistry
20 May 2020Assigned to Editor
20 May 2020Submission Checks Completed
01 Jun 2020Reviewer(s) Assigned